New gel could mean fewer applications for knee pain relief
NCT ID NCT06729073
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested how much of the pain-relieving drug diclofenac enters the bloodstream when applied as a gel to the knees. 34 healthy volunteers used a new once-daily gel (AMZ001) and a standard four-times-daily gel for 7 days each. The goal was to compare drug levels and check safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuvisan
Neu-Ulm, Germany